Benzinga's Top #PreMarket Losers

By: via Benzinga
Zafgen Inc (NASDAQ: ZFGN) fell 29.45 percent to $14.83 in pre-market trading on beloranib partial clinical hold. Wynn Resorts, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.